Medicine Description blotagril 75mg
Blotagril 75 mg tablets is a medication that works by inhibiting the binding of adenosine diphosphate (ADP) to its platelet receptor, P2Y12. This action prevents the activation of the glycoprotein IIb/IIIa complex, a critical step in platelet aggregation. By blocking this pathway, Blotagril reduces the ability of platelets to clump together and form clots, thereby lowering the risk of thrombotic events such as heart attacks and strokes. Its antiplatelet effects are especially significant in patients undergoing interventions like angioplasty or those with a history of cardiovascular events, enhancing overall vascular health and stability.
Indications and Uses of Blotagril 75 mg tablets
- Prevention of thrombotic events in patients with acute coronary syndrome
- Post-PCI management to prevent stent thrombosis
- Secondary prevention in patients with a history of myocardial infarction
- Reduction of the risk of stroke in individuals with a prior transient ischemic attack or stroke
- Management of peripheral artery disease to lessen the risk of cardiovascular events
Side Effects of Blotagril 75 mg tablets
- Bleeding complications, such as bruising or prolonged bleeding
- Gastrointestinal disturbances, including nausea and diarrhea
- Allergic reactions, such as rash or itching
- Thrombotic thrombocytopenic purpura (TTP), a rare but serious condition
- Fatigue or weakness
Storage and Handling
Store Blotagril 75 mg tablets at room temperature, away from excess moisture and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Patient Advice and Precautions
Patients should inform their healthcare provider about any current medications to avoid potential interactions. It is crucial to adhere to prescribed treatment plans and attend regular follow-up appointments to monitor health status. Report any unusual bleeding or bruising immediately, and discuss any concerns regarding side effects with a healthcare professional.